Surgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market (2024 - 2034)
Surgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market Study by Hemostats, Internal Tissue Sealants, and Adhesion Barriers for Surgeries and Trauma Cases from 2024 to 2034
Core Findings
FREE CustomizationSurgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market Outlook (2024 to 2034)
Expanding at a CAGR of 8.9%, the global surgical hemostat, internal tissue sealant, and adhesion barrier market is projected to increase from a valuation of US$ 5.72 billion in 2024 to US$ 13.46 billion by the end of 2034.
Surgical hemostats, internal tissue sealants, and adhesion barriers are implants that prevent internal scarring caused by tissue or organ adhesion. Medical devices and applications such as hemostats, internal compression, and hemostatic barriers are being used to manage excessive bleeding following surgery or during dental procedures.
Hemostats are medical devices used in dental procedures to stop excessive blood loss in patients who are bleeding heavily. They are also referred to as hemostatic forceps, arterial pressure gauges, or devices that resemble pean screws. Adhesive barriers are also used during gynecological, abdominal, cardiovascular, orthopedic/medicinal, and urological surgeries that involve internal tissues and organs.
Global market for surgical hemostats, internal tissue sealants, and adhesion barriers is expanding due to multiple factors such as robust healthcare systems and well-established reimbursement policies for healthcare procedures.
Key Market Growth Drivers
- Growing demand for cardiovascular, orthopedic, digestive, and other surgical procedures, along with the growing geriatric population across the globe, is set to contribute to the expansion of the surgical hemostat, internal tissue sealant, and adhesion barrier market size.
- The market for internal tissue sealants, adhesion barriers, and surgical hemostats is growing due to several factors, including an increase in sports injuries and spinal problems, an increase in the number of surgeries performed, and an increased need for compelling blood loss administration.
- Manufacturers are showing increasing interest in this industry to capture a significant portion of the global market, leading to heightened competition and market expansion.
- Increasing number of surgeries worldwide is one of the major drivers for the surgical hemostat, internal tissue sealant, and adhesion barrier market growth.
| Report Attributes | Details |
|---|---|
| Surgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market Size (2024E) | US$ 5.72 Billion |
| Forecasted Market Value (2034F) | US$ 13.46 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.9% CAGR |
| East Asia Market Growth Rate (2024E) | 9.9% CAGR |
| North America Market Share (2024E) | 53.8% |
| Sales of Internal Tissue Sealants (2024E) | US$ 2.24 Billion |
| Key Companies Profiled | Ethicon (Johnson & Johnson); Baxter International Inc.; Integra LifeSciences Holdings Corporation; Pfizer Inc.; Tissuemed Ltd.; Sanofi; Braun Melsungen AG; C.R. Bard Inc.; CryoLife Inc.; Cohera Medical Inc.; CSL Behring |
Why are Sales of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Rising Rapidly?
“Rising Incidence of Cardiovascular Diseases across Regions”
Increasing incidence of cardiovascular diseases is primarily responsible for the growing demand for tissue sealants and hemostats. The launch of more products aimed at controlling bleeding during surgeries is fueling global sales of surgical hemostats, internal tissue sealants, and adhesion barriers.
Depending on the type of injury, various hemostatic methods are employed, often composed of substances such as cellulose, gelatin, and oxidized regenerated collagen. Hemostats are available in different forms, including sponge, sheet, pad, matrix, gel, and powder, and find application in various surgical procedures, from general to neurological, thus driving market growth for these products.
What are the Hindrances to Market Growth?
“High Cost of Surgical Hemostats and Internal Tissue Sealants”
Treatment for internal tissue sealants, adhesion barriers, and surgical hemostats is becoming increasingly expensive. The high costs of these components are restricting their worldwide sales. Research and development into surgical hemostats and tissue sealants also entail increased expenses for manufacturers.
The rising cost of research & development means increased cost of the raw materials used for the preparation of polymers. The prolonged R&D process is also impeding market growth.
Country-wise Insights
North America is estimated to hold 50% surgical hemostat, internal tissue sealant, and adhesion barrier market share. Over the course of the forecast period from 2024 to 2034, North America is projected to maintain its leading position in the worldwide market. This is because cases of small bowel obstruction (SBO) are increasing in the region. Adhesion barriers are required to stop scar or adhesion formation in SBO.
Which Trends are Advantageous to Manufacturers in the United States?
“Increasing Number of Heart Transplants”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 2.4 Billion |
| Growth Rate (2024 to 2034) | 9.6% CAGR |
| Projected Value (2034F) | US$ 6 Billion |
The United States is estimated to account for 75% share of the North American market in 2024 due to increasing cases of cardiovascular diseases among more people in the country.
- As per the American Heart Association's Heart Disease and Stroke Statistics report released on February 22, 2022, 3,658 heart transplants were carried out in the country in 2020. California (496) had the maximum number of cases of heart transplants, followed by Texas (302), Florida (288), and New York (250). The most commonly performed procedure was cardiac catheterization.
- Inpatient procedures performed in the United States for patients included an estimated 480,000 percutaneous transluminal coronary angioplasties, 371,000 inpatient bypass procedures, 1,016,000 inpatient diagnostic cardiac catheterizations, 86,000 carotid endarterectomies, and 351,000 pacemaker procedures.
Why are Surgical Hemostat and Internal Tissue Sealant Producers Turning to Japan?
“Shift toward Minimally Invasive Surgical Techniques Fueling Demand for Hemostatic Products”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 200.7 Million |
| Growth Rate (2024 to 2034) | 10% CAGR |
| Projected Value (2034F) | US$ 472.2 Million |
Japan holds a significant share of the market in East Asia, and product sales are projected to rise at a noteworthy pace through 2034 due to technological advancements, rising surgical procedures, and the increasing prevalence of cardiovascular disorders among the aging population in the country.
There is a shift toward minimally invasive surgical techniques that necessitates the development of hemostatic products tailored to these procedures, thus driving market growth. This is one of the major surgical hemostat, internal tissue sealant, and adhesion barrier market trends.
- TENALEAF is a sheet-type absorbable adhesion barrier that is made in Japan. In February 2023, it was approved as a medical device by Gunze Limited, a Japan-based company. With its moderate adhesive strength allowing for conformable placement and easy manipulation, this product is offering surgeons a new option during open and minimally invasive surgeries.
Category-wise Insights
By product, the market is segmented into hemostats, internal tissue sealants, and adhesion barriers. Internal tissue sealants dominate the market attributed to increased wound-sealing needs and growing demand for affordable medical products in developing nations. Manufacturers are investing in R&D to enhance the functions of these devices. Hospitals hold a significant market share due to increased surgical procedures.
What are the Main Contributors to Rising Adoption of Internal Tissue Sealants?
“Growing Emphasis on Development of Bioresorbable Sealants”
| Attribute | Internal Tissue Sealants |
|---|---|
| Segment Value (2024E) | US$ 2.24 Billion |
| Growth Rate (2024 to 2034) | 9.1% CAGR |
| Projected Value (2034F) | US$ 5.35 Billion |
Manufacturers are dedicating resources to research and development to produce sealants with enhanced features, including improved sealing ability, reduced toxicity, and faster healing times. The development of bioresorbable sealants, eliminating the need for removal post-healing, is also gaining momentum.
Why Do Hospitals Extensively Use Hemostats, Tissue Sealants, and Adhesion Barriers?
“Access to Advanced Medical Technologies and Resources to Ensure Efficient Equipment Use”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 3.93 Billion |
| Growth Rate (2024 to 2034) | 8.8% CAGR |
| Projected Value (2034F) | US$ 9.15 Billion |
Based on end user, the surgical hemostat, internal tissue sealant, and adhesion barrier market is categorized into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals account for 70% market share in 2024.
Hospitals carry out a wide range of surgical procedures for diverse medical conditions, which necessitates the use of hemostats, sealants, and adhesion barriers. Hospitals have advanced medical technologies and resources to ensure efficient application and monitoring of these products during surgeries.
Competitive Landscape
Key players in the surgical hemostat, internal tissue sealant, and adhesion barrier market are Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard Inc., CryoLife Inc., Cohera Medical Inc., and CSL Behring.
- Salarius Pharmaceuticals, Inc., a biopharmaceutical company based in the United States, released preclinical data on December 5, 2022. SP-3164 is an experimental small molecule protein degrader or molecular glue that has the potential to exhibit enhanced anti-multiple myeloma activity. It inhibited the growth of cancer in a mouse model and caused lab-grown cancer cells to die. Therefore, it might be able to treat hematological cancers.
- DendroPrime is a thiol-ene-based coating that was assessed to determine its effectiveness as an adhesion barrier between a plate and flexor tendon in in-vivo models, according to an article published in the Journal of Hand Surgery on June 19, 2020. When DendroPrime was applied to the implanted plates, the mobility in the distal interphalangeal joint (DIP) joint was statistically significantly better than when the bare metal plates were left uncoated. In addition, the coating stopped soft tissue from growing around the implant, making removal simpler than it would have been for uncoated plates.
- The United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) approved RevBio Inc., a biotechnology company based in the United States, to launch a clinical trial for an enhanced version of its dental bone adhesive biomaterial Tetranite on September 15, 2022. Fifteen patients were to participate in clinical trials to evaluate the effectiveness and safety of dental implants that are stabilized right away after tooth extractions.
Segmentation of Surgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market Research
-
By Product Type :
- Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
-
By Application :
- Surgical Applicants
- Trauma Cases
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
- 5.1. Surgical Applicants
- 5.2. Trauma Cases
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type
- 6.1. Hemostats
- 6.2. Internal Tissue Sealants
- 6.3. Adhesion Barriers
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centers
- 7.3. Specialty Clinics
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. Ethicon (Johnson & Johnson)
- 16.2. Baxter International Inc.
- 16.3. Integra LifeSciences Holdings Corporation
- 16.4. Pfizer Inc.
- 16.5. Tissuemed Ltd.
- 16.6. Sanofi
- 16.7. Braun Melsungen AG
- 16.8. C.R. Bard Inc.
- 16.9. CryoLife Inc.
- 16.10. Cohera Medical Inc.
- 16.11. CSL Behring
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034
- FAQs -
What is the size of the surgical hemostat, internal tissue sealant, and adhesion barrier market?
The global market for surgical hemostats, internal tissue sealants, and adhesion barriers is estimated at US$ 5.72 billion in 2024.
Which country holds a significant market share in this business?
The United States is set to reach a market valuation of US$ 2.34 billion in 2024.
What is the market size of East Asia in 2024?
The East Asian market is estimated to reach US$ 566 million in 2024.
Which application type accounts for a significant share of the market?
Surgical applications are valued at US$ 3.72 billion in 2024.
Which end user accounts for high sales in surgical hemostats, internal tissue sealants, and adhesion barriers?
Hospitals account for around 68.9% market share in in 2024.
What is the projected market value for Japan in 2024?
Japan is projected to reach a market value of US$ 200.7 million in 2024.
Related Reports
Surgical Hemostat, Internal Tissue Sealant, and Adhesion Barrier Market